Conferenza stampa

MEDIA & PRESS UPDATES

 
Patrick Griss.png

NEW FINANCIAL ADVISOR

April 30, 2021

We are happy to welcome three new board advisors. Their expertise in innovation management in the MedTech industry will play a valuable role in guiding our future strategic decisions. We are confident that our advisors will give rise to new and exciting opportunities and help strengthen Lumendo's position in the endodontic market.

Today, we present our new financial advisor Dr. Patrick Griss:

After graduating with an M.Sc. in Microtechnology from EPF Lausanne (Switzerland), as well as a Ph.D. in Microsystem Technology from the KTH Royal Institute of Technology in Stockholm (Sweden), Dr. Patrick Griss is now an Executive Partner of Zühlke Ventures, a venture capital firm investing in medical device companies in Switzerland, Europe, America, and China.

2021-F21-Linkedinpost-Website-IH-1901-02

TECH TOUR FUTURE 21 TOP PRESENTERS

March 26, 2021

Our CEO Andreas Schmocker was selected among the top presenters of Future 21 Tech Tour. Congratulations!

Tech Tour is a collaborative forum that brings together founders, developers, and industry leaders to share the partnerships, inspiration, and solutions needed to promote world-class innovation.

Robert8Frigg.jpg

NEW ENTREPREUNARIAL ADVISOR

March 15, 2021

We are happy to welcome three new board advisors. We will present them during the next months. Their expertise in innovation management in the MedTech industry will play a valuable role in guiding our future strategic decisions. We are confident that our advisors will give rise to new and exciting opportunities and help strengthen Lumendo's position on the endodontic market.


Today, we present you Robert Frigg:

As an active medical device developer, Prof. Dr. h.c. mult. Robert Frigg has spent over 35 years in innovation management positions in the MedTech field. After almost 20 years working in different positions at the AO Foundation, including building up the AO Development Institute. From 1997 to 2003, he worked as VP of Innovation and New Concepts at Mathys Medical. From 2004 to 2012, he was worldwide responsible for technology and innovation as CTO at Synthes Inc., which was later sold to J&J for more than 20 billion USD. Since 2013, Robert Frigg setup and since 2019 owns 41medical, a MedTech company developing solutions for the human musculoskeletal system. 

TechTourFinalists.png

TECH TOUR ALPINE FINALIST

January 2021

After a successful virtual pitch session, Lumendo AG is proud and honored to be part of the 13 World Tour Finalist selected by TechTour Alpine.

Closeup of a Petri Dish

NEW GRANT FROM  THE SWISS INNOVATION AGENCY

June 1, 2020

Our hand-santizer project "Disigel" is receiving further support from the Swiss Innovation Agency (Innosuisse). Together with the Swiss Federal Laboratories for Materials Science and Technology (EMPA) and the SPIEZ LABORATORY, we will further develop and test the safety and efficacy against Sars-CoV-2.

DSC_9891.jpg

LUMENDO RECEIVES SUPPORT FROM THE GEBERT RÜF STIFTUNG

April 15, 2020

To help fighting the global Covid-19 pandemic, Lumendo received support from the Gebert Rüf Stiftung to develop a revolutionary, long-lasting hand sanitizer "Disigel". Find out  more in the project description and the press release.

schoolvisit-1920w_edited.jpg

SHAPING THE PROFESSIONALS OF TOMORROW

10 September 2019

A school class from the Liceo Artistico Zurich visited our R&D department and labs. The pupils learned about the fascinating world of light-curing materials and could try out our prototypes themselves in the lab.

download.png

BRIDGING THE RESEARCH FUNDS

August 2019

Lumendo CTO and co-founder Mark Bispinghoff is awarded the SNF BRIDGE "Proof of concept" grant for the project “Photopolymerizable, stable hydrogels for medical applications”.

DSC_9768.jpg

LUMENDO IS AWARDED THE 100K FIT GRANT

July 2019

Lumendo is awarded the 100k FIT grant. The "Foundation for Technological Innovation" helps funding innovative projects in the canton of Vaud and provides appropriate financial assistance to startups.

prix-perl-2019-770x513.jpg

LUMENDO WON THE PERL PUBLIC PRIZE

May 2019

Lumendo wins the Public Price at PERL.

download.png

AGEFI SPEAKS ABOUT US

April 2019

Lumendo is in the news: Lumendo is mentioned by AGEFI, Société de l’Agence Economique et Financière S.A. related to the nomination of PERL (Prix Entreprendre Lausanne Région).

hello.jpg

HELLO TOMORROW CHALLENGE IN PARIS

March 2019

Lumendo is among 80 deep-tech startups from around the world that have qualified for the finals of the Hello Tomorrow Challenge in Paris.

Gebert Rüf.png

GEBERT RÜF FOUNDATION FUNDS OUR PRODUCT DEVELOPMENT.

July 2018

We are happy to receive support by the Gebert Rüf Foundation for the development of our endodontic sealer.

bilan.png

INTERVIEW FOR BILAN MAGAZINE

Jun 2018

The biweekly business magazine Bilan features an article describing how Lumendo wants to revolutionize how dentist place root canal fillings.

DSC_0151.jpg

FEATURED IN THE ETH INDUSTRY NEWSLETTER.

February 2018

Lumendo’s story is covered in the ETH Industry Newsletter.

venture kick.png

VENTUREKICK STAGE THREE

October 2017

After winning Venturekick stage 1 and 2, Lumendo convinces the jury another time and wins stage 3.

lab.png

SELECTED AS VENTURE LEADER LIFE SCIENCE 2017

July 2017

Lumendo CEO and co-founder Andreas Schmocker is selected as a Venture Leader Life Science 2017. This enables him to travel to Boston as part of the Swiss National Startup Team to explore the US startup scene and the US dental and medical device market.

Schneider+Ammann+and+Lumigbo+and+Christi

TOP ONE BUSINESS PLAN @VENTURE.CH COMPETITION

June 2017

Lumendo wins the Venture.ch competition in the categorie Top1 Business plan, selected out of 126 entries.

DSC_9768.jpg

ETH PIONEER FELLOWSHIP AWARDED

May 2017

Lumendo CTO and co-founder Mark Bispinghoff is awarded the ETH Pioneer Fellowship to turn his PhD research into a commercial product. ETH Zürich and the ETH Zürich foundation grants financial support and free lab and office space.

Scientist on Tablet

INNOGRANT FUEL OUR PROJECT

December 2016

Lumendo CEO and co-founder Andreas Schmocker is awarded the EPFL Innogrant